ALPMY OTC
Astellas Pharma Inc.
1W: -4.3%
1M: -5.3%
3M: +5.1%
YTD: +7.5%
1Y: +29.9%
3Y: +6.2%
5Y: -7.3%
$14.32
-0.12 (-0.83%)
Weekly Expected Move ±3.8%
$13
$14
$14
$15
$15
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$600.4B
+208.7% ▲
5Y CAGR: +14.3%
Capital Expenditures
$61.2B
-6.8% ▼
5Y CAGR: -4.6%
Free Cash Flow
$539.2B
+293.1% ▲
5Y CAGR: +18.5%
Dividends Paid
$144.3B
-11.9% ▼
Buybacks
$774M
+88.9% ▲
Net Change in Cash
$81.6B
+155.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $124.1B | $98.7B | $17.0B | $31.2B | $309.1B |
| Depreciation & Amort. | $79.7B | $105.7B | $157.8B | $199.1B | $1.3B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$10.7B | $74.0B | -$86.5B | -$166.4B | $29.0B |
| Other Non-Cash Items | $65.1B | $53.9B | $84.1B | $130.5B | $262.2B |
| Operating Cash Flow | $258.2B | $332.3B | $172.5B | $194.5B | $600.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$76.4B | -$88.5B | -$38.1B | -$37.0B | -$89.7B |
| Acquisitions (Net) | -$229M | $0 | -$785.0B | $0 | $0 |
| Investment Purchases | -$5.6B | $0 | $0 | $0 | $0 |
| Investment Sales | $5.6B | $12.6B | $0 | $12.9B | $0 |
| Other Investing | $13.5B | -$13.1B | -$22.8B | -$65.3B | $12.6B |
| Investing Cash Flow | -$63.1B | -$89.1B | -$845.8B | -$89.4B | -$77.2B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$60.0B | -$15.0B | $771.2B | -$88.5B | -$86.7B |
| Stock Repurchased | -$50.7B | -$60.6B | -$10.7B | -$7.0B | -$774M |
| Dividends Paid | -$85.2B | -$100.4B | -$116.7B | -$129.0B | -$144.3B |
| Other Financing | -$20.3B | -$19.7B | -$29.8B | -$36.9B | -$197.4B |
| Financing Cash Flow | -$216.3B | -$195.6B | $614.1B | -$261.4B | -$429.2B |
| Net Change in Cash | -$10.1B | $60.9B | -$41.2B | -$147.3B | $81.6B |
| Cash End of Period | $316.0B | $376.8B | $335.7B | $188.4B | $282.8B |
| Free Cash Flow | $181.7B | $243.8B | $90.0B | $137.2B | $539.2B |